Described herein are pharmaceutical packaging devices which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medication, such methods including a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with extremely minimal permeability to oxygen and comprises